- Late-breaker presentation to feature data from VANTAGE study evaluating volixibat in primary biliary cholangitis FOSTER CITY, Calif., November 14, 2024--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. ...
Source Link- Late-breaker presentation to feature data from VANTAGE study evaluating volixibat in primary biliary cholangitis FOSTER CITY, Calif., November 14, 2024--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. ...
Source Link
Comments